Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 6/20 | 0.59 |
| ▸ | CES2 | O00748 | 3/20 | 0.59 |
| ▸ | CES1 | P23141 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1167722 | 0.79 | L3MBTL1 (0.52) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL28960147 | 0.78 | TDP1 (0.56) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL727901 | 0.78 | SRC (0.56) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL4380823 | 0.76 | CES1 (0.58) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL2927912 | 0.76 | L3MBTL1 (1.00) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL1667152 | 0.76 | TDP1 (0.67) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL29719387 | 0.76 | TDP1 (0.59) | TDP1L3MBTL1LMNACES2CES1 | |
| Benzoin SCHEMBL29167409 | 0.76 | LMNA (0.91) | TDP1L3MBTL1LMNACES2CES1 | |
| Benzoin SCHEMBL10646810 | 0.76 | LMNA (0.91) | TDP1L3MBTL1LMNACES2CES1 | |
| Benzoin SCHEMBL27562303 | 0.76 | LMNA (0.91) | TDP1L3MBTL1LMNACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0531382-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-03-17 | — | — | EP | claimed |
| US-11702571-B2 | Adhesive sheet for temporary fixation and method of manufacturing semiconductor device using the same | LG CHEM, LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| CN-111655811-B | Adhesive sheet for temporary attachment and method of manufacturing semiconductor device using the same | 株式会社LG化学 | 2022-04-15 | — | — | CN | disclosed |
| CN-111225963-B | Adhesive sheet for temporary fixation and method for manufacturing semiconductor device using the same | 株式会社LG化学 | 2022-02-22 | — | — | CN | disclosed |
| US-20210171802-A1 | ADHESIVE SHEET FOR TEMPORARY FIXATION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| CN-111655811-A | Adhesive sheet for temporary attachment and method of manufacturing semiconductor device using the same | 株式会社LG化学 | 2020-09-11 | — | — | CN | disclosed |
| CN-111225963-A | Adhesive sheet for temporary fixation and method for manufacturing semiconductor device using the same | 株式会社LG化学 | 2020-06-02 | — | — | CN | disclosed |
| WO-2019199085-A1 | ADHESIVE SHEET FOR TEMPORARY ATTACHMENT AND SEMICONDUCTOR DEVICE PRODUCING METHOD USING SAME | 주식회사 엘지화학 | 2019-10-17 | — | — | WO | disclosed |
| WO-2019190242-A1 | ADHESIVE SHEET FOR TEMPORARY FIXING, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE BY USING SAME | 주식회사 엘지화학 | 2019-10-03 | — | — | WO | disclosed |
| US-6753410-B2 | ANALYZING THE PROCESSING OF AMYLOID PROTEIN PRECURSOR (APP); ALZHEIMER'S DISEASE; ENZYME INHIBITORS OF GAMMA-SECRETASE, A PROTEASE, AND INHIBITS PROTEOLYSIS OF PRESENILIN-1 ON WHICH THE SECRETASE ACTIVITY IS DEPENDENT | MERCK & CO., INC. | 2004-06-22 | — | — | US | disclosed |
| US-20020013276-A1 | Investigational compounds | MERCK & CO., INC. | 2002-01-31 | — | — | US | disclosed |
| EP-0531382-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013276-A1 | Investigational compounds | CBR1, CBR3, CNR1 | TDP1 2634/4885L3MBTL1 2299/4885LMNA 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.